Chromium picolinate supplementation "beneficial" in type 2 diabetics in USDA study.
This article was originally published in The Tan Sheet
Executive Summary
CHROMIUM PICOLINATE ELEVATED INTAKE FOUND "BENEFICIAL" FOR DIABETICS in a study by Richard Anderson, PhD, U.S. Department of Agriculture, et al., in collaboration with Beijing Medical University. Published in the November issue of Diabetes, the research involved 180 subjects 35 to 65 with type 2 adult-onset diabetes. Patients received chromium picolinate in 200 mcg or 1,000 mcg doses daily or placebo. "Improvements in fasting glucose and insulin concentrations as well as those after a glucose challenge document the role of elevated intakes of supplemental chromium in the control of type 2 diabetes," the study says.